These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 6191123)

  • 21. Concepts behind the development of multiple drug therapy regimens in leprosy.
    Waters MF
    Lepr Rev; 1986 Dec; 57 Suppl 1():61-7. PubMed ID: 3295437
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug resistance of Mycobacterium leprae, particularly to DDS.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(4):625-38. PubMed ID: 4173566
    [No Abstract]   [Full Text] [Related]  

  • 23. [Employment of a program in the leprosy campaign in Mayotte based on the use of rifampicin and clofazimine].
    Blanchy S; Galtier J
    Acta Leprol; 1982; (88):19-22. PubMed ID: 6818815
    [No Abstract]   [Full Text] [Related]  

  • 24. Rifampicin resistant leprosy: a review and a research proposal of a pilot study.
    Ji B
    Lepr Rev; 2002 Mar; 73(1):2-8. PubMed ID: 11969122
    [No Abstract]   [Full Text] [Related]  

  • 25. Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae.
    Pattyn SR
    Lepr Rev; 1973 Sep; 43(3):126-36. PubMed ID: 4120832
    [No Abstract]   [Full Text] [Related]  

  • 26. A overview of ocular leprosy after 2 decades of multidrug therapy.
    Lewallen S; Courtright P
    Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278
    [No Abstract]   [Full Text] [Related]  

  • 27. Antileprosy drugs.
    Br Med J; 1971 Jul; 3(5767):174-6. PubMed ID: 4104273
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [How should leprosy be treated?].
    Mahé A
    Ann Dermatol Venereol; 1998 Dec; 125(12):881-3. PubMed ID: 9922859
    [No Abstract]   [Full Text] [Related]  

  • 30. Multidrug resistant Mycobacterium leprae from patients with leprosy.
    Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evaluation of present antileprosy compounds.
    Browne SG
    Adv Pharmacol (1962); 1969; 7():211-51. PubMed ID: 4190238
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma levels of chemokines during leprosy specific treatment.
    Mendonça VA; Costa RD; Lyon S; Penido RA; Borges VO; Bretas TL; Antunes CM; Teixeira MM; Teixeira AL
    Acta Trop; 2010 Feb; 113(2):151-4. PubMed ID: 19874796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs.
    Almeida JG
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367
    [No Abstract]   [Full Text] [Related]  

  • 34. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
    You EY; Kang TJ; Kim SK; Lee SB; Chae GT
    J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea.
    Lee SB; Kim SK; Kang TJ; Chae GT; Chun JH; Shin HK; Kim JP; Ko YH; Kim NH
    Ann Trop Med Parasitol; 2001 Jun; 95(4):429-32. PubMed ID: 11454253
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment failure in leprosy.
    Levy L
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):177-82. PubMed ID: 776854
    [No Abstract]   [Full Text] [Related]  

  • 37. Application of the mouse foot-pad technique in immunologically normal mice in support of clinical drug trials, and a review of earlier clinical drug trials in lepromatous leprosy.
    Levy L
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):823-9. PubMed ID: 3325574
    [No Abstract]   [Full Text] [Related]  

  • 38. Clofazimine-resistant leprosy, a case report.
    Warndorff-van Diepen T
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):139-42. PubMed ID: 6749703
    [No Abstract]   [Full Text] [Related]  

  • 39. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
    Williams DL; Araujo S; Stryjewska BM; Scollard D
    Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leprosy.
    Marcos LA; Conerly S; Walker S
    Am J Trop Med Hyg; 2014 Aug; 91(2):216. PubMed ID: 25100789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.